Vivek K Jayaraman, the Chief Operating Officer of $CERS, sold 16,667 shares of the company on 05-29-2026 for an estimated $50,001. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.0% of their shares of this class of stock. Following this trade, they now own 1,656,707 shares of this class of $CERS stock.
$CERS Insider Trading Activity
$CERS insiders have traded $CERS stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $CERS stock by insiders over the last 6 months:
- WILLIAM MARINER GREENMAN (President and CEO) has made 0 purchases and 2 sales selling 525,944 shares for an estimated $898,826.
- VIVEK K JAYARAMAN (Chief Operating Officer) has made 0 purchases and 4 sales selling 232,628 shares for an estimated $442,146.
- RICHARD J BENJAMIN (Chief Medical Officer) has made 0 purchases and 4 sales selling 227,634 shares for an estimated $419,541.
- KEVIN DENNIS GREEN (Chief Financial Officer) has made 0 purchases and 3 sales selling 210,565 shares for an estimated $381,012.
- CHRYSTAL JENSEN (Chief Legal Officer) sold 30,845 shares for an estimated $61,859
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CERS Hedge Fund Activity
We have seen 84 institutional investors add shares of $CERS stock to their portfolio, and 79 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOLEUS CAPITAL MANAGEMENT, L.P. added 6,753,700 shares (+168.8%) to their portfolio in Q1 2026, for an estimated $12,291,734
- MORGAN STANLEY removed 1,114,173 shares (-57.4%) from their portfolio in Q1 2026, for an estimated $2,027,794
- DRIEHAUS CAPITAL MANAGEMENT LLC added 961,606 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,750,122
- UBS GROUP AG added 956,851 shares (+83.8%) to their portfolio in Q1 2026, for an estimated $1,741,468
- CITADEL ADVISORS LLC removed 945,020 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,719,936
- TWO SIGMA INVESTMENTS, LP added 887,911 shares (+47.8%) to their portfolio in Q1 2026, for an estimated $1,615,998
- ARK INVESTMENT MANAGEMENT LLC removed 649,984 shares (-3.4%) from their portfolio in Q4 2025, for an estimated $1,338,967
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CERS Revenue
$CERS had revenues of $59.9M in Q1 2026. This is an increase of 22.6% from the same period in the prior year.
You can track CERS financials on Quiver Quantitative's CERS stock page.
You can access data on CERS stock through the Quiver Quantitative API.
$CERS Analyst Ratings
Wall Street analysts have issued reports on $CERS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 05/01/2026
To track analyst ratings and price targets for $CERS, check out Quiver Quantitative's $CERS forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
